Detail akcie Stereotaxis online

Business Summary: Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Financial Summary: BRIEF: For the three months ended 31 March 2026, Stereotaxis Inc revenues decreased 16% to $6.3M. Net loss applicable to common stockholders increased 1% to $6.2M. Revenues reflect Systems decrease of 33% to $1.3M, Disposables, service and accessories decrease of 10% to $5M. Higher net loss reflects Manufactures and markets robotic magnetic navigation systems segment loss increase of 1% to $6M.